SMMT vs. LMN.V
SMMT (Summit Therapeutics Inc.) and LMN.V (Lumine Group Inc) are both stocks. SMMT operates in Biotechnology (Healthcare), while LMN.V operates in Software - Application (Technology). Over the past 3 years, SMMT returned 93.96%/yr vs 6.58%/yr for LMN.V. At a 0.06 correlation, their price movements are largely independent.
Performance
SMMT vs. LMN.V - Performance Comparison
Loading charts...
Different Trading Currencies
SMMT is traded in USD, while LMN.V is traded in CAD. To make them comparable, the LMN.V values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, SMMT achieves a -19.90% return, which is significantly lower than LMN.V's -15.80% return.
SMMT
- 1D
- 7.11%
- 1M
- -25.44%
- YTD
- -19.90%
- 6M
- -20.26%
- 1Y
- -30.51%
- 3Y*
- 93.96%
- 5Y*
- 15.49%
- 10Y*
- 5.31%
LMN.V
- 1D
- 0.75%
- 1M
- 14.68%
- YTD
- -15.80%
- 6M
- -18.48%
- 1Y
- -50.33%
- 3Y*
- 6.58%
- 5Y*
- —
- 10Y*
- —
SMMT vs. LMN.V - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
SMMT Summit Therapeutics Inc. | -19.90% | -1.99% | 583.72% | 53.53% |
LMN.V Lumine Group Inc | -15.80% | -30.87% | 26.85% | 90.78% |
Correlation
The correlation between SMMT and LMN.V is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Mar 24, 2023 | 0.06 |
Fundamentals
SMMT:
$10.86B
LMN.V:
CA$5.99B
SMMT:
-$1.60
LMN.V:
$0.48
SMMT:
19.90
LMN.V:
5.16
SMMT:
$0.00
LMN.V:
$792.89M
SMMT:
-$83.36K
LMN.V:
$271.95M
SMMT:
-$738.34M
LMN.V:
$253.96M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SMMT vs. LMN.V — Risk / Return Rank
SMMT
LMN.V
SMMT vs. LMN.V - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and Lumine Group Inc (LMN.V). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SMMT | LMN.V | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.54 | ||
| Sortino ratioReturn per unit of downside risk | +1.49 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 0.83 | +0.16 |
| Calmar ratioReturn relative to maximum drawdown | -0.55 | -0.76 | +0.21 |
| Martin ratioReturn relative to average drawdown | -0.87 | -1.09 | +0.22 |
Loading charts...
Drawdowns
SMMT vs. LMN.V - Drawdown Comparison
The maximum SMMT drawdown since its inception was -95.75%, which is greater than LMN.V's maximum drawdown of -66.63%. Use the drawdown chart below to compare losses from any high point for SMMT and LMN.V.
Loading charts...
Drawdown Indicators
| SMMT | LMN.V | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.75% | -66.63% | -29.12% |
Max Drawdown (1Y)Largest decline over 1 year | -55.49% | -66.63% | +11.14% |
Max Drawdown (3Y)Largest decline over 3 years | -64.44% | -66.63% | +2.19% |
Max Drawdown (5Y)Largest decline over 5 years | -91.78% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -95.75% | — | — |
Current DrawdownCurrent decline from peak | -61.83% | -58.05% | -3.78% |
Average DrawdownAverage peak-to-trough decline | -57.63% | -18.14% | -39.49% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.94% | 46.16% | -11.22% |
Volatility
SMMT vs. LMN.V - Volatility Comparison
Summit Therapeutics Inc. (SMMT) has a higher volatility of 23.99% compared to Lumine Group Inc (LMN.V) at 12.52%. This indicates that SMMT's price experiences larger fluctuations and is considered to be riskier than LMN.V based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SMMT | LMN.V | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.99% | 12.52% | +11.47% |
Volatility (6M)Calculated over the trailing 6-month period | 56.65% | 39.07% | +17.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.61% | 53.20% | +22.41% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 185.08% | 45.29% | +139.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 144.46% | 45.29% | +99.17% |
Dividends
SMMT vs. LMN.V - Dividend Comparison
Neither SMMT nor LMN.V has paid dividends to shareholders.
Financials
SMMT vs. LMN.V - Financials Comparison
This section allows you to compare key financial metrics between Summit Therapeutics Inc. and Lumine Group Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SMMT and LMN.V have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for SMMT and LMN.V
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer